Related Experiment Video
Updated: Mar 13, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Development and Validation of a Prediction Model for Overt Hepatic Encephalopathy (OHE) After Transjugular
Jie Long1, Yi Li1, Zenglong Que2
1Department of Gastroenterology, Daping Hospital, Army Medical University, No.10 Changjiang Branch Road, Daping, Yuzhong District, Chongqing 400042, China.
Background:
Hepatic encephalopathy (HE), especially overt HE (OHE), is the most common transjugular intrahepatic portosystemic shunt (TIPS) complication, affecting quality of life. Existing noninvasive models have suboptimal predictive performance.
Aim:
To develop a novel model integrating preoperative and intraoperative indicators to predict post-TIPS OHE.
Methods:
We included 455 TIPS patients from three centers (Army Medical Center, Xinqiao Hospital, and West China Hospital) between March 2018 and September 2024, randomly allocated into 7:3 development and validation cohorts. LASSO and multivariate logistic regression identified independent risk factors, with model discrimination/calibration evaluated against traditional models (Child-Pugh, model for end-stage liver disease [MELD], albumin-bilirubin [ALBI], and Freiburg index of post-TIPS survival [FIPS]).
Results:
A total of 455 patients were included. During follow-up, 91 patients (28.4%) in the development cohort and 41 (30.4%) patients in the validation cohort developed OHE. The analysis identified the following independent risk factors: peripheral blood monocyte count (odds ratio [OR] = 1.40, 95% confidence interval [CI]: 1.22-1.63, P < 0.001), thrombin time (TT; OR = 1.35, 95% CI: 1.15-1.59, P < 0.001), age (OR = 1.08, 95% CI: 1.05-1.12, P < 0.001), history of diabetes (OR = 7.64, 95% CI: 3.50-17.55, P < 0.001), ascites grade [mild-moderate ascites (OR = 2.35, 95% CI: 1.19-4.77, P = 0.02), severe ascites (OR = 3.76, 95% CI: 1.15-12.64, P = 0.03)]. Stent underdilated (8-mm stent dilated to 6-mm) was a strong independent protective factor (OR = 0.12, 95% CI: 0.05-0.26, P < 0.001). The six-factor prediction model achieved area under the curve values of 0.864 (development cohort) and 0.812 (validation cohort), significantly outperforming Child-Pugh (0.617/0.656), MELD (0.551/0.569), ALBI (0.607/0.662), and FIPS (0.667/0.608) scores (all P < 0.05).
Conclusion:
The prediction model incorporating stent dilatation status, peripheral blood monocyte count, TT, age, ascites severity, and history of diabetes demonstrates high predictive accuracy for assessing OHE risk after TIPS. Notably, the model was derived in a mainly hepatitis B virus-cirrhosis Asian population, which may limit generalizability to alcoholic/nonalcoholic steatohepatitis-dominant western populations.
Related Concept Videos
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...

